Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2002
12/04/2002EP1262183A1 Use of norastemizole for the treatment of allergic rhinitis
12/04/2002EP1262182A2 Methods and compositions for treating hypertension, angina and other disorders using optically pure(-) amlodipine
12/04/2002EP1262181A1 Urease inhibitors
12/04/2002EP1262180A1 Tnf-alpha inhibitors
12/04/2002EP1262179A1 Photodynamic therapy for selectively closing neovasa in eyeground tissue
12/04/2002EP1262178A2 Suppressor of anemia and appetite suppressor comprising threonine alone or in combination with methionine
12/04/2002EP1262177A2 Medical use of thyromimetic compounds to treat hair loss and compositions
12/04/2002EP1262176A1 Method of treating or inhibiting neutrophil chemotaxis by administering a mek inhibitor
12/04/2002EP1262175A2 Use of renin-angiotensin antagonist for reducing post myocardial infarct mobidity and mortality
12/04/2002EP1262173A1 Oral intake solution comprising reduced water
12/04/2002EP1262169A2 Skin anti-ageing composition
12/04/2002EP1262166A1 Cosmetic and/or pharmaceutical compositions containing a Pterocarpus marsupium extract
12/04/2002EP1262163A1 Composition having a liquid fatty phase gelified by a semicrystalline polymer
12/04/2002EP1261714A2 Muteins of interleukin-13 (il-13)
12/04/2002EP1261713A2 Human ion channels
12/04/2002EP1261712A2 Proteins named fctrx and nucleic acids encoding same
12/04/2002EP1261708A2 Compositions and methods for the therapy and diagnosis of prostate cancer
12/04/2002EP1261707A1 5ht3 receptors of nematodes, polynucleotide molecules encoding same, and antagonists thereof
12/04/2002EP1261691A2 Serum free cultivation of primate embryonic stem cells
12/04/2002EP1261640A2 Inflammation-related gene
12/04/2002EP1261639A2 Chondromodulin-i related peptide
12/04/2002EP1261638A2 Human fgf-23 gene and gene expression products
12/04/2002EP1261616A2 Modified oligonucleotides for mismatch discrimination
12/04/2002EP1261613A1 Gastro-specific prodrugs
12/04/2002EP1261611A2 Inhibitors of hepatitis c virus ns3 protease
12/04/2002EP1261610A2 Succinoylamino carbocycles and heterocycles as inhibitors of a-beta protein production
12/04/2002EP1261609A1 Triazolotriazinones and the use thereof
12/04/2002EP1261607A1 2,4-disubstituted thiazolyl derivatives
12/04/2002EP1261606A1 Substituted oxazolidinones and their use in the field of blood coagulation
12/04/2002EP1261605A1 Benzoxazole derivatives as tnf and pde iv inhibitors
12/04/2002EP1261604A1 Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them
12/04/2002EP1261603A1 Flavone derivatives, preparation method and use as medicines
12/04/2002EP1261602A1 Imidazol-2-carboxamide derivatives as raf kinase inhibitors
12/04/2002EP1261601A1 Substituted indoles for modulating nfkb activity
12/04/2002EP1261600A1 Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2
12/04/2002EP1261598A1 Internal 1,15-lactones of fluprostenol and related prostaglandin f2alpha analogs and their use in the treatment of glaucoma and intraocular hypertension
12/04/2002EP1261595A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
12/04/2002EP1261594A1 5,10-dihydroacridines as calcium channel blockers
12/04/2002EP1261593A1 8,8a-dihydro-indeno 1,2-d]thiazole derivatives with a sulphonamido or sulphono substituent in the 2 position, a method for production thereof and use thereof as a medicament
12/04/2002EP1261590A1 Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
12/04/2002EP1261589A1 Imidazole compounds and their use as adenosine deaminase inhibitors
12/04/2002EP1261588A1 New imidazole derivatives
12/04/2002EP1261586A2 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv, processes for their preparation, and their use
12/04/2002EP1261585A1 Substituted indole mannich bases
12/04/2002EP1261583A1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES
12/04/2002EP1261579A1 Dehydroamino acids
12/04/2002EP1261379A2 Genetic modification of the lung as a portal for gene delivery
12/04/2002EP1261377A2 Immunomodulatory formulations and methods for use thereof
12/04/2002EP1261375A2 Compositions with enhanced oral bioavailability
12/04/2002EP1261374A2 Farnesyl protein transferase inhibitor combinations with further anti-cancer agents
12/04/2002EP1261373A2 Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions
12/04/2002EP1261372A2 Method of treating cancer with anti-neurotrophin agents
12/04/2002EP1261366A1 Adjuvant treatment by in vivo activation of dendritic cells
12/04/2002EP1261363A2 METHODS FOR TREATING FSH RELATED CONDITIONS WITH GnRH ANTAGONISTS
12/04/2002EP1261362A2 Novel amino acid and peptide inhibitors of staphylococcus virulence
12/04/2002EP1261361A1 Oral, nasal and pulmonary dosage formualtions of copolymer 1
12/04/2002EP1261358A1 Use of a composition
12/04/2002EP1261356A2 Farnesyl protein transferase inhibitor combinations with platinum compounds
12/04/2002EP1261355A1 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response
12/04/2002EP1261354A1 Delivery system and methods for gene therapy
12/04/2002EP1261353A2 Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections
12/04/2002EP1261352A2 Immunostimulatory polynucleotide sequences for use in preventing and treating respiratory viral infections
12/04/2002EP1261351A2 Nystatin formulation having reduced toxicity
12/04/2002EP1261349A1 Compounds with chelation affinity and selectivity for first transition series elements and their use
12/04/2002EP1261348A2 Combinations of a farnesyl protein transferase inhibitor with nitrogen mustard or nitrosourea alkylating agents
12/04/2002EP1261347A1 Therapeutic compositions and methods for treatingperiodontitis with antiinflamatory compounds
12/04/2002EP1261346A1 Modulation of cardiovascular injury
12/04/2002EP1261345A1 Herbal supplement for cognitive related impairment due to estrogen loss
12/04/2002EP1261343A2 Farnesyl protein transferase inhibitor combinations with anti-tumor nucleoside derivatives
12/04/2002EP1261342A2 Farnesyl protein transferase inhibitor combinations
12/04/2002EP1261341A2 Farnesyl protein transferase inhibitor combinations with camptothecin compounds
12/04/2002EP1261340A2 Compositions and methods for the treatment of parkinson's disease
12/04/2002EP1261339A1 Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
12/04/2002EP1261338A1 Compositions and methods for treatment of epilepsy
12/04/2002EP1261337A2 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
12/04/2002EP1261336A2 Il-8 receptor antagonists
12/04/2002EP1261335A1 Brain, spinal and nerve injury treatment
12/04/2002EP1261334A1 Irrigation solution containing mapk inhibitors and their use for treating pain and inflammation
12/04/2002EP1261333A1 Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
12/04/2002EP1261332A1 Use of cyp1b1 inhibitors for treating cancer
12/04/2002EP1261331A1 Method and compositions for treating fibrotic diseases
12/04/2002EP1261330A2 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and in lower animals
12/04/2002EP1261329A2 Il-8 receptor antagonists
12/04/2002EP1261328A1 Il-8 receptor antagonists
12/04/2002EP1261327A2 Adenosine receptor modulators
12/04/2002EP1261326A1 D-enantiomer of dfmo and methods of use therefor for treating cancer
12/04/2002EP1261325A2 Nitroacridine/tumor inhibitor compositions
12/04/2002EP1261324A2 Tramadol for the treatment of functional gastrointestinal disorders
12/04/2002EP1261323A2 Method of treating gastrointestinal tract disease with purinergic receptor agonists
12/04/2002EP1261322A2 Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
12/04/2002EP1261321A2 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof
12/04/2002EP1261320A2 Micellar pharmaceutical compositions for buccal and pulmonary application
12/04/2002EP1261318A2 Concentrated solution of quaternary ammonium compounds and methods of use
12/04/2002EP1261317A2 Methods and compositions for treating and preventing posterior segment ophthalmic disorders
12/04/2002EP1261310A1 Cosmetic and pharmaceutical preparations for treating cellulite
12/04/2002EP1261309A1 Device for calculating elixir doses appropriate for a patient's weight
12/04/2002EP1261259A1 Treatment of infection in animals
12/04/2002EP1261254A2 Method of controlling zoological and aquatic plant growth
12/04/2002EP1180026B1 Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
12/04/2002EP1158962B1 Method for producing solid dosage forms containing cyclodextrin
1 ... 5632 5633 5634 5635 5636 5637 5638 5639 5640 5641 5642 5643 5644 5645 5646 5647 5648 5649 5650 5651 5652 ... 7860